Item 2. Management’s Discussion and Analysis
Item 2. Management’s Discussion
and Analysis of Financial Condition and Results of Operations
References in this report (the “Quarterly
Report”) to “we,” “us” or the “Company” refer to M3-Brigade Acquisition V Corp. References
to our “management” or our “management team” refer to our officers and directors, and references to the “Original
Sponsor” refer to M3-Brigade Sponsor V LLC and “Sponsor” refer to MI7 Sponsor, LLC. The following discussion and analysis
of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial
statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis
set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking
statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act that are not historical
facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All
statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Proposed Business Combination
(as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations,
are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,”
“estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking
statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs,
based on information currently available. A number of factors could cause actual events, performance or results to differ materially from
the events, performance and results discussed in the forward-looking statements, including that the conditions of the Business Combination
are not satisfied. For information identifying important factors that could cause actual results to differ materially from those anticipated
in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public
Offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be
accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the
Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information,
future events or otherwise.
Overview
We are a blank check company incorporated in the
Cayman Islands on March 12, 2024 formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization
or other similar Business Combination with one or more businesses. We intend to effectuate our Business Combination using cash derived
from the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our shares, debt or a combination of
cash, shares and debt.
We expect to continue to incur significant costs
in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
Business Combination Agreement
On July 7, 2025, the Company, ReserveOne, Inc.,
a Delaware corporation (“ReserveOne”), ReserveOne Holdings, Inc., a Delaware corporation and wholly-owned subsidiary of ReserveOne
(“Pubco”), R1 SPAC Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Pubco (“SPAC Merger Sub”),
and R1 Company Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Pubco (“Company Merger Sub” and,
together with the SPAC Merger Sub, the “Merger Subs”), entered into a business combination agreement (the “Business
Combination Agreement”).
As a result of the transactions contemplated by
the Business Combination Agreement, the Company will be de-registered in the Cayman Islands and register by way of continuation to the
State of Delaware and domesticate as a Delaware corporation (the “Domestication”).
24
Following the Domestication, SPAC Merger Sub will
merge with and into the Company (the “SPAC Merger”), with the Company continuing as the surviving entity (the “SPAC
Surviving Subsidiary”), and as a result of which the Company will be a wholly-owned subsidiary of Pubco. Promptly following the
SPAC Merger, Company Merger Sub will merge with and into ReserveOne (the “Company Merger” and, together with the SPAC Merger,
the “Mergers”), with ReserveOne continuing as the surviving company (the “Company Surviving Subsidiary”), and
as a result of which ReserveOne will be a wholly-owned subsidiary of Pubco.
As a result of the Mergers, Pubco will become
a publicly traded company, all upon the terms and subject to the conditions set forth in the Business Combination Agreement and in accordance
with applicable laws.
The shares of Pubco Class A common stock, par
value $0.0001 per share, will be listed for trading and will be freely transferable, subject to the transfer restrictions set forth in
the Sponsor Support Agreement and the Lock-Up Agreement and any restrictions pursuant to applicable laws. The shares of Pubco Class B
common stock, par value $0.0001 per share, will not be listed or freely transferable.
The Closing is expected to occur in the first
quarter of 2026, subject to the satisfaction of certain customary closing conditions.
Results of Operations
We have neither engaged in any operations nor
generated any revenues to date. Our only activities from March 12, 2024 (inception) through September 30, 2025, were organizational activities,
those necessary to prepare for the Initial Public Offering, described below, and identifying a target company for a Business Combination.
We do not expect to generate any operating revenues until after the completion of our Business Combination. We generate non-operating
income in the form of interest income on cash and marketable securities held in the Trust Account. We incur expenses as a result of being
a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended September 30, 2025,
we had a net loss of $491,393, which consists of $2,868,287 of general and administrative costs and compensation expense of $765,773,
offset by $3,142,667 from interest earned on marketable securities held in Trust Account.
For the nine months ended September 30, 2025,
we had a net income of $4,606,168, which consists of $9,331,539 from interest earned on marketable securities held in Trust Account, offset
by $3,913,871 of general and administrative costs and compensation expense of $811,500.
For the three months ended September 30, 2024,
we had a net income of $2,010,116, which consists of $2,305,244 from interest earned on marketable securities held in Trust Account, offset
by $295,128 of general and administrative costs.
For the period from March 12, 2024 (inception)
through September 30, 2024, we had net income of $1,960,642, which consists of $2,305,244 from interest earned on cash held in Trust Account,
offset by $344,602 of general and administrative costs.
Liquidity and Capital Resources
Until the consummation of the Initial Public Offering,
our only source of liquidity was an initial purchase of Class B ordinary shares, par value $0.0001 per share, by the Original Sponsor
and loans or advances from the Original Sponsor or another related party.
On August 2, 2024, we consummated the Initial
Public Offering of 28,750,000 Units at $10.00 per Units, which includes the full exercise by the underwriters of their over-allotment
option in the amount of 3,750,000 Units generating gross proceeds of $287,500,000. Simultaneously with the closing of the Initial Public
Offering, we consummated the sale of an aggregate of 8,337,500 Private Placement Warrants at a price of $1.00 per Private Placement Warrant,
in a private placement to the Original Sponsor and Cantor Fitzgerald & Co., the representative of the underwriters of the initial
Public Offering, generating gross proceeds of $8,337,500. On May 27, 2025, the Original Sponsor and Cantor Fitzgerald & Co. sold their
Private Placement Warrants to the Sponsor.
25
Following the Initial Public Offering, the full
exercise of the over-allotment option, and the sale of the Units, a total of $288,937,500 was placed in the Trust Account. We incurred
$19,406,996 of transaction costs, consisting of $5,000,000 of cash underwriting fees, $13,400,000 of deferred underwriting fees, and $1,006,996
of other offering costs.
On June 16, 2025, the Company issued the Note
to the Sponsor, pursuant to which the Company can borrow up to an aggregate principal amount of $2,500,000 from the Sponsor. The Note
bears no interest and is payable on the Maturity Date. A failure to pay the principal on the Maturity Date shall be deemed an event of
default, in which case the Note may be accelerated. If the Company does not consummate an initial business combination, the Note will
be repaid solely to the extent the Company has funds available outside its trust account established in connection with the Company’s
initial public offering. On July 16, 2025, the Company and the Sponsor entered into the First Amendment to the Note (the “Note Amendment”),
solely to correct a scrivener’s error regarding the Sponsor’s option to convert up to $1,500,000 of the outstanding unpaid
principal balance under the Note into Private Placement Warrants at a purchase price of $1.50 per Private Placement Warrant. Pursuant
to the Note Amendment, the purchase price per Private Placement Warrant was corrected to reflect a purchase price of $1.00 per Private
Placement Warrant upon conversion under the Note. All other terms of the Note remain unchanged
On June 18, 2025 and September 19, 2025 the Company
borrowed $500,000 and $1,500,000, respectively, under the Note. The proceeds of the Note will be used to provide the Company with general
working capital.
As of September 30, 2025, we had marketable securities
held in the Trust Account of $303,948,781. We may withdraw interest from the Trust Account to pay taxes, if any. We intend to use substantially
all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes
payable), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration
to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the
operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of September 30, 2025, we had cash of $1,683,134.
We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence
on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their
representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate
and complete a Business Combination.
In order to fund working capital deficiencies
or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their
affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such
loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the
Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of
such Working Capital Loans, which would include any potential borrowings under the Note, may be convertible into private placement warrants
of the post Business Combination entity at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to
the Private Placement Warrants.
The Company may need to raise additional
funds, other than any potential borrowings under the Note, in order to fund the expenditures required for operating its business.
However, if the estimate of the costs of completing the transactions contemplated by the agreement with respect to an initial
Business Combination Agreement with ReserveOne and its affiliates are less than the actual amount necessary to do so, the Company
may have insufficient funds available to operate its business prior to the completion of the transactions contemplated by the
Business Combination Agreement.
Moreover, we may need to obtain additional financing
either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation
of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.
26
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities,
which would be considered off-balance sheet arrangements as of September 30, 2025. We do not participate in transactions that create relationships
with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established
for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
Contractual obligations
We do not have any long-term debt, capital lease obligations, operating
lease obligations or long-term liabilities.
The underwriters had a 45-day option from the
date of the Initial Public Offering to purchase up to an additional 3,750,000 units to cover over-allotments, if any. Simultaneously
with the closing of the Initial Public Offering, the underwriters elected to fully exercise the over-allotment option to purchase the
additional 3,750,000 Units at a price of $10.00 per Unit.
Critical Accounting Policies
The preparation of unaudited condensed financial
statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets
and liabilities at the date of the unaudited condensed financial statements, and income and expenses during the periods reported. Actual
results could materially differ from those estimates. We have identified no critical accounting policies.
Recent Accounting Standards
Management does not believe that any recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our unaudited condensed financial
statements.
Item 3. Quantitative and Qualitative Disclosures
About Market Risk
Not required for smaller reporting companies.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.